Yes the junior resource sector has its problems as I know from personal experience. The ASX can't prevent the worst examples (crooks will be crooks), but a set of effective guideline would go a long way to dampening down the hype that many biotechs are forced into just to raise funds.
SP Manipulation, page-16
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $12.80K | 670.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1054218 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 785473 | 7 |
View Market Depth
| Last trade - 14.54pm 19/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |